Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Hikma, African Barrick, Lenovo

Fri, 17th Aug 2012 06:58

What a difference a year makes, Tempus in The Times proclaims. When the Arab Spring was in full flow, investors worried that Hikma Pharmaceuticals was too exposed to the unstable region. The company, based in Jordan, almost halved last year's sales growth forecast as governments fell. Now it looks well placed to benefit from the region's recovery ? and investors are grateful that it has largely escaped the eurozone crisis, which has seen governments slash healthcare spending. The company is gradually shifting production to the developing world, where costs are cheaper. Analysts say that Hikma has better growth prospects than its European rivals, a view confirmed by yesterday's results. Shares rose five per cent yesterday, but are still off the high reached before the Arab Spring unfolded. Now an Arab Spring premium should apply. Buy, says Tempus.Hold African Barrick Gold (ABG) until the bid situation becomes clear is the advice of Questor in the Daily Telegraph. Two state-owned companies have approached African Barrick Gold's (ABG) parent company Barrick Gold with a view to making an offer for part, or whole, of ABG. Barrick Gold is continuing talks with China National Gold, after it apparently rejected a low-ball bid from Zijin Mining Group. Questor thinks Barrick Gold is more likely to sell a portion of its stake rather than sell out completely. This latest move by China may or may not mark the start of a wave of mergers in gold miners. However, the sector certainly looks ripe for consolidation for companies with the financial muscle to buy quality assets. Questor last said ABG shares were a speculative buy on July 24th when they stood at 317p. They are now 34% above that level and because the bid situation is unclear, the rating is now cut to hold.Chinese companies know all about "zouchuqu" - going out and staking a claim in global markets whatever the cost, observes Lex, as the Financial Times's venerable column takes a look at the world's second largest PC maker, Lenovo. On Thursday, the PC maker said that in the past three months it increased revenues 35% from a year earlier, and widened its paper-thin margins enough to increase operating profit by nearly 50%. Good work, but there is more to be done. While Lenovo's share in the PC market is now just short of global leader Hewlett-Packard's, its operating margins are a quarter of HP's. Progress may take time, though. This month it announced a partnership with EMC, the US storage server group that once worked with Dell. Margins are fatter in the server market, but Lenovo will be up against tough competitors in HP, IBM and Dell, who control three-quarters of it. However, any Chinese company that has proved it can combine global ambition and improving profitability deserves the benefit of the doubt.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.JH
More News
23 Jun 2020 09:11

Boehringer Sells 27 Million Hikma Shares For GBP625 Million Amid Exit

Boehringer Sells 27 Million Hikma Shares For GBP625 Million Amid Exit

Read more
23 Jun 2020 09:08

LONDON MARKET OPEN: Stocks Rise After Mixed Signals On US-China Trade

LONDON MARKET OPEN: Stocks Rise After Mixed Signals On US-China Trade

Read more
23 Jun 2020 09:05

MORNING BID-PMI cheer?

A look at the day ahead from EMEA deputy markets editor Sujata Rao. The views expressed are her own.June flash PMI readings are providing markets with something to cheer about. After robust improvements in Australia and Japan, the French flash PMI...

Read more
23 Jun 2020 08:49

UPDATE 3-European stocks close near 2-week high as PMI data brings cheer

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Euro zone downturn eases further in June - PMI data* White House assures U.S.-China trade deal still intact* Bayer gains after reports of nearing glyphosate settlement (Updat...

Read more
23 Jun 2020 08:48

LIVE MARKETS-Opening snapshot: French, German upbeat PMIs boost shares

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...

Read more
23 Jun 2020 08:19

Hikma Pharmaceuticals slumps as Boehringer Ingelheim sells stake

(Sharecast News) - Hikma Pharmaceuticals shares slumped on Tuesday after major shareholder German pharmaceutical group Boehringer Ingelheim sold off its 16.5% stake in the company.

Read more
23 Jun 2020 08:14

LONDON BRIEFING: St James's Place Maintains Fund Inflows Amid Pandemic

LONDON BRIEFING: St James's Place Maintains Fund Inflows Amid Pandemic

Read more
23 Jun 2020 07:44

LIVE MARKETS-On the radar: Fresh PMIs, UK lockdown easing and Sanofi's vaccine

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...

Read more
7 Jun 2020 12:37

Sunday share tips: Hikma Pharmaceuticals, Vinacapital Vietnam Opportunity Fund

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'buy' shares of Hikma Pharmaceuticals, touting it as a potential beneficiary of the White House's 'America First' strategy to promote US manufacturing.

Read more
22 May 2020 11:03

UK WINNERS & LOSERS SUMMARY: easyJet Lower Ahead Of Board Ouster Bid

UK WINNERS & LOSERS SUMMARY: easyJet Lower Ahead Of Board Ouster Bid

Read more
22 May 2020 09:29

Hikma Gets US FDA Approval For Generic Version Of Heart Drug Vascepa

Hikma Gets US FDA Approval For Generic Version Of Heart Drug Vascepa

Read more
22 May 2020 09:04

LONDON MARKET OPEN: Stocks Open Down; easyJet Set For Stelios Showdown

LONDON MARKET OPEN: Stocks Open Down; easyJet Set For Stelios Showdown

Read more
22 May 2020 07:33

Hikma gets FDA approval for generic version of 'Vascepa'

(Sharecast News) - Hikma Pharmaceuticals announced on Friday that its wholly-owned US subsidiary has received approval from the US Food and Drug Administration (FDA) for its icosapent ethyl capsules at one gram, which is its generic equivalent to 'Vascepa'.

Read more
4 May 2020 09:43

UPDATE 2-FTSE 100 ends lower on U.S.-China tensions

* FTSE 100 down 0.2%, FTSE 250 drops 1.2%* Rolls Royce slumps on reports of job cuts* Health care, energy stocks gain* Largest UK firms expect 20% hit to sales in 2020 -survey (Updates with market closing)By Devik Jain and Sagarika JaisinghaniMay 4 ...

Read more
30 Apr 2020 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.